Massive haematuria successfully managed by intravesical ankaferd in a haemodialysis patient complicated with disseminated intravascular coagulation

Yalcin Solak, Abduzhappar Gaipov, Orhan Ozbek, Mustafa Aziz Hassan, Mehdi Yeksan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Massive haematuria is a life-threatening condition, demanding immediate management of bleeding. The mortality is very high in the case of delayed management of bleeding, especially in elderly patients with concomitant comorbidity. The treatment options of haematuria are wide, and depend on underlying conditions. However, therapeutic choices are limited in the presence of massive and intractable haematuria caused by disseminated intravascular coagulation (DIC). Ankaferd blood stopper (ABS) is a novel, commercially available, haemostatic agent, which has been approved by the Ministry of Health for local use in Turkey. Here, for the first time in the literature, we report a case of diffuse intravesical bleeding stopped by intravesical use of ABS in a 72-year-old man, haemodialysis patient complicated with sepsis and DIC.

Original languageEnglish
Article number1411
JournalBMJ Case Reports
DOIs
Publication statusPublished - Jan 1 2012
Externally publishedYes

Fingerprint

Disseminated Intravascular Coagulation
Hematuria
Renal Dialysis
Hemorrhage
Case Management
Hemostatics
Turkey
Comorbidity
Sepsis
Mortality
Health
Therapeutics
ankaferd blood stopper

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Massive haematuria successfully managed by intravesical ankaferd in a haemodialysis patient complicated with disseminated intravascular coagulation. / Solak, Yalcin; Gaipov, Abduzhappar; Ozbek, Orhan; Hassan, Mustafa Aziz; Yeksan, Mehdi.

In: BMJ Case Reports, 01.01.2012.

Research output: Contribution to journalArticle

@article{f7ab0a941fc642d38a28b43aa82e2390,
title = "Massive haematuria successfully managed by intravesical ankaferd in a haemodialysis patient complicated with disseminated intravascular coagulation",
abstract = "Massive haematuria is a life-threatening condition, demanding immediate management of bleeding. The mortality is very high in the case of delayed management of bleeding, especially in elderly patients with concomitant comorbidity. The treatment options of haematuria are wide, and depend on underlying conditions. However, therapeutic choices are limited in the presence of massive and intractable haematuria caused by disseminated intravascular coagulation (DIC). Ankaferd blood stopper (ABS) is a novel, commercially available, haemostatic agent, which has been approved by the Ministry of Health for local use in Turkey. Here, for the first time in the literature, we report a case of diffuse intravesical bleeding stopped by intravesical use of ABS in a 72-year-old man, haemodialysis patient complicated with sepsis and DIC.",
author = "Yalcin Solak and Abduzhappar Gaipov and Orhan Ozbek and Hassan, {Mustafa Aziz} and Mehdi Yeksan",
year = "2012",
month = "1",
day = "1",
doi = "10.1136/bcr-2012-006699",
language = "English",
journal = "BMJ Case Reports",
issn = "1757-790X",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Massive haematuria successfully managed by intravesical ankaferd in a haemodialysis patient complicated with disseminated intravascular coagulation

AU - Solak, Yalcin

AU - Gaipov, Abduzhappar

AU - Ozbek, Orhan

AU - Hassan, Mustafa Aziz

AU - Yeksan, Mehdi

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Massive haematuria is a life-threatening condition, demanding immediate management of bleeding. The mortality is very high in the case of delayed management of bleeding, especially in elderly patients with concomitant comorbidity. The treatment options of haematuria are wide, and depend on underlying conditions. However, therapeutic choices are limited in the presence of massive and intractable haematuria caused by disseminated intravascular coagulation (DIC). Ankaferd blood stopper (ABS) is a novel, commercially available, haemostatic agent, which has been approved by the Ministry of Health for local use in Turkey. Here, for the first time in the literature, we report a case of diffuse intravesical bleeding stopped by intravesical use of ABS in a 72-year-old man, haemodialysis patient complicated with sepsis and DIC.

AB - Massive haematuria is a life-threatening condition, demanding immediate management of bleeding. The mortality is very high in the case of delayed management of bleeding, especially in elderly patients with concomitant comorbidity. The treatment options of haematuria are wide, and depend on underlying conditions. However, therapeutic choices are limited in the presence of massive and intractable haematuria caused by disseminated intravascular coagulation (DIC). Ankaferd blood stopper (ABS) is a novel, commercially available, haemostatic agent, which has been approved by the Ministry of Health for local use in Turkey. Here, for the first time in the literature, we report a case of diffuse intravesical bleeding stopped by intravesical use of ABS in a 72-year-old man, haemodialysis patient complicated with sepsis and DIC.

UR - http://www.scopus.com/inward/record.url?scp=84872725474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872725474&partnerID=8YFLogxK

U2 - 10.1136/bcr-2012-006699

DO - 10.1136/bcr-2012-006699

M3 - Article

JO - BMJ Case Reports

JF - BMJ Case Reports

SN - 1757-790X

M1 - 1411

ER -